<DOC>
	<DOCNO>NCT01722617</DOCNO>
	<brief_summary>Rheumatoid arthritis ( RA ) rheumatic inflammatory synovitis characterize pain joint swell well thicken synovial ( pannus ) lesions responsible osteocartilaginous tendon damage . It evolve spurt long variable intensity intersperse remission . The effectiveness treatment base proportion patient achieve certain degree improvement initial level various parameter response criterion ACR 20 , 50 70 % EULAR base evolution DAS 28 DAS 44 . These response criterion well validate fully take account improvement patient 's condition . In contrast , questionnaire identify proportion patient whose RA worsen medical visit . Such questionnaire necessary detect flare outbreaks daily practice randomize clinical trial , follow-up study longitudinal study drug market detect reversal disease activity . Both STPR group OMERACT group develop new self-administered questionnaire ( FLARE OM-RA-FLARE ) detect flare- RA patient . The objective study validate questionnaire FLARE OM-RA-FLARE among RA patient use methodology advocate OMERACT term validity ( truth ) , discriminate power ( discrimination ) feasibility</brief_summary>
	<brief_title>A Study Validate Questionnaires FLARE OM-RA-FLARE Measuring Disease Flares Patients With Rheumatoid Arthritis .</brief_title>
	<detailed_description>There 6 month follow include 3 medical visit patient : - M0 ( medical visit inclusion ) - follow M0 - M3 - M3 ( medical visit 3 month inclusion ) - follow M3 - M6 - M6 ( medical visit 6 month inclusion ) At inclusion visit ( M0 ) , verification inclusion non-inclusion criterion , follow information collect : - Socio-demographical data : age , sex , level education ( primary , secondary , college , university ) , occupational category ( INSEE 6 category ) - Items ACR 1987 ACR/EULAR 2010 ; - Length RA - Erosive ( presence Yes / ) - IgM rheumatoid factor ( presence Yes / No ) - Anti CCP antbodies ( presence Yes / No ) During follow-up visit ( M3 M6 ) , element collect : 1. study technician ( TEC ) - inflammatory activity index , evaluate patient ( RAPID-3 ) ; - functional limitation index ( HAQ ) ; - PASS questionnaire ; - OM-RA-FLARE questionnaire ; - FLARE questionnaire . 2. doctor : - element DAS 28 , include blood test do city hospital ; - doctor 's decision end consultation , term : - DMRADs : continue treatment , decrease increase dose , change due ineffectiveness , change due patient ' intolerance . - Symptomatic treatment : continue corticosteroid , increase dose corticosteroid , corticosteroid infiltration .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Age â‰¥ 18 year ; Having Rheumatoid Arthritis ( RA ) since 6 month , meet ACR 1987 ACR / EULAR 2010 ; Treatment RA : Treatment disease modify antirheumatic drug ( DRMADs ) biological treatment stable 2 month ; Symptomatic treatment ( include corticosteroid ) stable 2 month ; Receive medical exam first ; Agreed sign informed consent form ; Ability comply study protocol ; Having social insurance coverage Patients undergo surgery study period ; Patients without affiliation social security coverage ( entitled beneficiary ) ; Patients guardianship trusteeship .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>